Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

TP53 Abnormality in Myelodysplastic Syndrome

Fei Huang, Yu Chen, Yuxing Zhu, Chun Qiao, Sixuan Qian, Jianyong Li, MD, Wenyi Shen, MD

Blood (2019) 134 (Supplement_1): 5410.

https://doi.org/10.1182/blood-2019-128054

Published: 2019

Journal Articles

Clinical and Genetic Features of Constitutional Partial Trisomy 8 Mosaicism (CT8M) Patients with Cytopenia

Blood (2019) 134 (Supplement_1): 5413.

https://doi.org/10.1182/blood-2019-129711

Published: 2019

Journal Articles

Plasmacytoid Dendritic Cell Proportion Is Predictive of Risk and Outcomes in Myelodysplastic Syndromes

Alexander Chan, MD, Yanming Zhang, MD, Sean M. Devlin, PhD, Natasha Lewis, MD, Jeeyeon Baik, Maria E Arcila, MD, Virginia M. Klimek, MD, Mikhail Roshal, MD PhD, Wenbin Xiao, MD PhD

Blood (2019) 134 (Supplement_1): 5439.

https://doi.org/10.1182/blood-2019-122332

Published: 2019

Journal Articles

Impact of HFE gene Variants on Iron Overload, Overall Survival and Leukemia-Free Survival in Myelodysplastic Syndromes

Mathias A. Schneeweiss, Greiner Georg, MD PhD, Susanne Herndlhofer, Julia Schellnegger, Maria-Theresa Krauth, MD, Friedrich Wimazal, MD, Corinna Steinhauser, Renate Thalhammer, MD, Ilse Schwarzinger, MD, Harald Esterbauer, MD PhD, Manuela Födinger, Peter Valent, MD, Wolfgang R. Sperr, MD

Blood (2019) 134 (Supplement_1): 4269.

https://doi.org/10.1182/blood-2019-123390

Published: 2019

Journal Articles

Germinal Predisposition in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction: Identification of Deleterious Variants in Microsatellite Instability Genes

Blood (2019) 134 (Supplement_1): 4226.

https://doi.org/10.1182/blood-2019-127204

Published: 2019

Journal Articles

Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)

Guadalupe Belen Antelo, MD, Giacomo Coltro, MD, Abhishek A Mangaonkar, MBBS, Terra Lasho, PhD, Christy Finke, BS, Ryan M. Carr, MD PhD, Naseema Gangat, MBBS, Moritz Binder, MDMPH, Aref Al-Kali, MD, Michelle A Elliott, MD, Matthew T Howard, MD, Rebecca L. King, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Martin Fernandez-Zapico, MD, Mrinal M Patnaik, MDMBBS

Blood (2019) 134 (Supplement_1): 4182.

https://doi.org/10.1182/blood-2019-126199

Published: 2019

Journal Articles

Variable Response to BCL2 Inhibition in MDS Is Enhanced across MDS Subtypes with Synergistic Combination of BCL2+MCL1 Inhibition

Melissa A. Fischer, MSc, PhD, Maria Arrate, MSc, Merrida A Childress, PhD, Brianna N Smith, MD MS, Yuanbin Song, MD, Rana Gbyli, MS, Thomas Stricker, MD PhD, Stephanie Halene, MD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 2982.

https://doi.org/10.1182/blood-2019-126578

Published: 2019

Journal Articles

Marrow Ring Sideroblasts Are Highly Predictive for TP53 Mutation in MDS with Excess Blasts

David M Swoboda, MD, Jung-Hoon Lee, MD, Onyee Chan, MD, Rami S. Komrokji, MD, Najla Al Ali, M.Sc, Eric Padron, MD, Alan F. List, MD, Mohammad O Hussaini, MD, Jinming Song, MD PhD, David A Sallman, MD

Blood (2019) 134 (Supplement_1): 4244.

https://doi.org/10.1182/blood-2019-124772

Published: 2019

Journal Articles

Therapy-Related Myeloid Neoplasms Following Treatment for Multiple Myeloma : A Single-Center Analysis

Amelie Boquoi, MD, Soraya Magdalena Banahan, MD, Judith Strapatsas, MD, David Lopez y Niedenhoff, MD, Guido Kobbe, MD, Norbert Gattermann, MD, Ulrich Germing, MD, Rainer Haas, MD, Thomas Schroeder, MD, Roland Fenk, MD

Blood (2019) 134 (Supplement_1): 4261.

https://doi.org/10.1182/blood-2019-122598

Published: 2019

Journal Articles

Germline and Acquired Genetic Variants in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction

Blood (2018) 132 (Supplement 1): 4339.

https://doi.org/10.1182/blood-2018-99-116045

Published: 2018

Journal Articles

Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

Ling Zhang, MD, Donald M Stablein, PhD, Pearlie Epling-Burnette, PhD PharmD, Alexandra M. Harrington, MDMT(ASCP), Lynn C. Moscinski, MD, Steven Kroft, MD, Amy E. DeZern, MD, Tareq Al Baghdadi, MD, Jane Jijun Liu, MD, Matthew J. Walter, MD, Rafael Bejar, MD PhD, Edward J. Gorak, DO, MBA, MS, Rami S. Komrokji, MD, Gregory A. Abel, MD MPH, Bart L Scott, MD, Steven D. Gore, MD, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 4370.

https://doi.org/10.1182/blood-2018-99-116629

Published: 2018

Journal Articles

Exploring Imaging Flow Cytometry As a Tool for Evaluating Dyserythropoiesis in Myelodysplastic Syndrome

Carina A Rosenberg, MSc, PhD, Marie Bill, MD PhD, Gitte Birk Kerndrup, MD DMSc, Mathias Hauerslev, Peter Hokland, MD DMSc, Maja Ludvigsen, MSc, PhD

Blood (2018) 132 (Supplement 1): 5508.

https://doi.org/10.1182/blood-2018-99-111555

Published: 2018

Journal Articles

Automated Early Detection of Myelodysplastic Syndrome with Beckman-Coulter DxH 800 Hematologyanalyzer By Using Ten Research Parameters

Noemie Ravalet, PharmD, Frederic Picou, PhD, Martin Gombert, PharmD, Amelie Foucault, PharmD, Emmanuel Renoult, Emmanuel Gyan, MD PhD, Sebastien Lachot, MD, Emmanuelle Rault, PharmD, Olivier Herault, MD PhD

Blood (2018) 132 (Supplement 1): 5509.

https://doi.org/10.1182/blood-2018-99-116054

Published: 2018

Journal Articles

Impact of Red Cell Distribution Width on Dysplasia and Clinical Outcome in 66 Patients with Myelodysplastic Syndrome without Increased Blasts

Yuta Baba, PhD MD, Bungo Saito, MD PhD, Shotaro Shimada, MD, Yohei Sasaki, MD, So Murai, MD, Maasa Abe, MD, Shun Fujiwara, MD, Nana Arai, MD, Yukiko Kawaguchi, MD, Nobuyuki Kabasawa, MD, Hiroyuki Tsukamoto, MD PhD, Yui Uto, MD PhD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD PhD

Blood (2018) 132 (Supplement 1): 5522.

https://doi.org/10.1182/blood-2018-99-113973

Published: 2018

Journal Articles

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

Andrea Kuendgen, MD, Meritxell Nomdedeu, Heinz Tuechler, Guillermo Garcia-Manero, MD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD MS, Matteo Giovanni Della Porta, Alan F. List, MD, Mario Cazzola, Amy E. DeZern, MD, Gail J. Roboz, MD, David P. Steensma, MD, Arjan A. Van de Loosdrecht, MD PhD, Hartmut Döhner, MD, Xavier Calvo, MD, Sabine Blum, Arturo Pereira, MD PhD, Peter Valent, Dolors Costa, Aristoteles Giagounidis, Luis Benlloch, Uwe Platzbecker, Carme Pedro, MD, Michael Lübbert, Itziar Oiartzabal, Javier Grau, Maria Díez-Campelo, María Teresa Cedena, Sigrid Machherndl-Spandl, MD, Maria López-Pavía, Claudia D. Baldus, MD, Montserra Martinez-de-Sola, Reinhard Stauder, MD MSc, Brayan Merchan, Christina Ganster, Thomas Schroeder, Barbara Hildebrandt, Jordi Esteve, MD PhD, Benet Nomdedeu, Francesc Cobo, Francesc Sole, PhD, Rainer Haas, MD, Ulrich Germing, MD, Peter L Greenberg, MD, Detlef Haase, MD PhD, Guillermo Sanz

Blood (2018) 132 (Supplement 1): 3103.

https://doi.org/10.1182/blood-2018-99-118215

Published: 2018

Journal Articles

A Phase 1 Trial of Ibrutinib (IBR) and Azacitidine (AZA) for the Treatment of Higher-Risk Myelodysplastic Syndromes (HR-MDS): Updated Results of University of California Hematologic Malignancies Consortium (UCHMC) Study 1503

Brian A. Jonas, MD PhD, Peter T. Curtin, MD, Gary J. Schiller, MD, Deepa Jeyakumar, MD, Matthew J. Wieduwilt, MD PhD, Mehrdad Abedi, MD, Rafael Bejar, MD PhD, Helen Chow, MD, Leslie G. Oesterich, MD, Aaron C. Logan, MD PhD

Blood (2018) 132 (Supplement 1): 3088.

https://doi.org/10.1182/blood-2018-99-119237

Published: 2018

Journal Articles

Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s) in a Single Institute in Saudi Arabia

Randa M Alnounou, MD, Mahmoud Aljurf, MD

Blood (2017) 130 (Supplement 1): 5311.

https://doi.org/10.1182/blood.V130.Suppl_1.5311.5311

Published: 2017

Journal Articles

Oxidative Stress in Stem / Progenitor Cells and Specific Antioxidant Response in Bone Marrow from Myelodysplastic Syndrome Patients

Frederic Picou, PhD, Christine Vignon, PhD, Joelle Hanna, MD, Sebastien Lachot, MD, Marie-Helene Estienne, PharmD, Amelie Foucault, Frederic Mazurier, PhD, Florence Rouleux-Bonnin, PhD, Fabrice Gouilleux, PhD, Jorge Domenech, MDPhD, Emmanuel Gyan, MDPhD, Michaela Fontenay, MD PhD, Olivier Herault, MDPhD

Blood (2017) 130 (Supplement 1): 2951.

https://doi.org/10.1182/blood.V130.Suppl_1.2951.2951

Published: 2017

Journal Articles

Prognostic Impact of ASXL1 Mutations and Extent of Bone Marrow Dysplasia in Patients with Who - defined Myelodysplastic Syndrome with Ring Sideroblasts

Abhishek Mangaonkar, MD, Terra L. Lasho, PhD, Christy Finke, BS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle A. Elliott, MD, Kebede H. Begna, MD, Hassan Alkhateeb, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Alexandra Wolanskyj, MD, William J. Hogan, MBBCh, Animesh Pardanani, MBBS PhD, Mark R. Litzow, MD, Ayalew Tefferi, MD, Mrinal M. Patnaik, MDMBBS

Blood (2017) 130 (Supplement 1): 2971.

https://doi.org/10.1182/blood.V130.Suppl_1.2971.2971

Published: 2017

Journal Articles

A Simple Complete Blood Count to Screen for Myelodysplastic Syndromes

Robin Boutault, PharmD, Pierre Peterlin, MD, Marouane Boubaya, PhD, Yannick LE Bris, MDPharmD, Catherine Godon, MD, Olivier Theisen, MD, Marie C Bene, PharmD,DPhil, Marion Eveillard, PharmD, PhD

Blood (2017) 130 (Supplement 1): 5296.

https://doi.org/10.1182/blood.V130.Suppl_1.5296.5296

Published: 2017

NARROW

TP53 Abnormality in Myelodysplastic Syndrome

Clinical and Genetic Features of Constitutional Partial Trisomy 8 Mosaicism (CT8M) Patients with Cytopenia

Plasmacytoid Dendritic Cell Proportion Is Predictive of Risk and Outcomes in Myelodysplastic Syndromes

Impact of HFE gene Variants on Iron Overload, Overall Survival and Leukemia-Free Survival in Myelodysplastic Syndromes

Germinal Predisposition in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction: Identification of Deleterious Variants in Microsatellite Instability Genes

Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)

Variable Response to BCL2 Inhibition in MDS Is Enhanced across MDS Subtypes with Synergistic Combination of BCL2+MCL1 Inhibition

Marrow Ring Sideroblasts Are Highly Predictive for TP53 Mutation in MDS with Excess Blasts

Therapy-Related Myeloid Neoplasms Following Treatment for Multiple Myeloma : A Single-Center Analysis

Germline and Acquired Genetic Variants in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction

Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

Exploring Imaging Flow Cytometry As a Tool for Evaluating Dyserythropoiesis in Myelodysplastic Syndrome

Automated Early Detection of Myelodysplastic Syndrome with Beckman-Coulter DxH 800 Hematologyanalyzer By Using Ten Research Parameters

Impact of Red Cell Distribution Width on Dysplasia and Clinical Outcome in 66 Patients with Myelodysplastic Syndrome without Increased Blasts

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

A Phase 1 Trial of Ibrutinib (IBR) and Azacitidine (AZA) for the Treatment of Higher-Risk Myelodysplastic Syndromes (HR-MDS): Updated Results of University of California Hematologic Malignancies Consortium (UCHMC) Study 1503

Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s) in a Single Institute in Saudi Arabia

Oxidative Stress in Stem / Progenitor Cells and Specific Antioxidant Response in Bone Marrow from Myelodysplastic Syndrome Patients

Prognostic Impact of ASXL1 Mutations and Extent of Bone Marrow Dysplasia in Patients with Who - defined Myelodysplastic Syndrome with Ring Sideroblasts

A Simple Complete Blood Count to Screen for Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only